Inhibiting cholesterol de novo synthesis promotes hepatocellular carcinoma progression by upregulating prostaglandin E synthase 2‐mediated arachidonic acid metabolism under high fatty acid conditions
Cancer Science · 2024
DOI: 10.1111/cas.16035 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Science, 2024. Verfasst von Zhibo Zhao und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hepatobiliary Surgery, Centre for Lipid Research and Key Laboratory of Molecular Biology for Infectious Diseases (Ministry of Education…. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Liver Neoplasms. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Chongqing Municipality, Scientific and Technological Research Program of Chongqing Municipal Education Commission.
Abstract (Originalsprache)
Inhibition of cholesterol de novo synthesis (DNS) by statins has controversial effects on the treatment of hepatocellular carcinoma (HCC). High fatty acid conditions have been reported to limit the effect of statins on metabolism diseases. Whether high fatty acid conditions interfere with the effect of statins on HCC remains unclear. Here, we reported that inhibiting cholesterol DNS with atorvastatin promoted the oncogenic capabilities of diethylnitrosamine (DEN) in mice fed high fatty acid diets (HFD). The combined analysis of metabolomics and transcriptomics revealed that arachidonic acid (AA) metabolism was the most significant changed pathway between mice with and without atorvastatin treatment. In vitro, in the presence of AA precursor linoleic acid (LA), atorvastatin promoted the proliferation and migration ability of HCC cell lines. However, in the absence of LA, these phenomena disappeared. TCGA and tissue microarray examination revealed that prostaglandin e synthase 2 (PTGES2), a key enzyme in AA metabolism, was associated with the poor outcome of HCC patients. Overexpression of PTGES2 promoted the proliferation and migration of HCC cell lines, and knockdown of PTGES2 inhibited the proliferation and migration of cells. Additionally, atorvastatin upregulated PTGES2 expression by enhancing Sterol‐regulatory element binding protein 2 (SREBP2)‐mediated transcription. Knockdown of PTGES2 reversed the proliferation and migration ability enhanced by atorvastatin. Overall, our study reveals that a high fatty acid background is one of the possible conditions limiting the application of statins in HCC, under which statins promote the progression of HCC by enhancing SREBP2‐mediated PTGES2 transcription.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Hepatobiliary Surgery, Centre for Lipid Research and Key Laboratory of Molecular Biology for Infectious Diseases (Ministry of Education), the Second Affiliated Hospital, Chongqing Medical University, Chong…
- Department of General Surgery, The People's Hospital of Jianyang City, Jianyang, China.
- Chengdu University of Traditional Chinese Medicine Affiliated Fifth People's hospital, Chengdu, China.
ORCID-Profile: Zhibo Zhao
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Chongqing Municipality
- Scientific and Technological Research Program of Chongqing Municipal Education Commission
- Talent Project of Chongqing
- Natural Science Foundation of Chongqing
Zitieren
APA
Zhao, Z., Liu, X., Xiang, Y., Hou, Z., He, K., Zhong, G., Hu, J., Cai, D., Liu, Y., Ren, J., Gong, J., & Zhao, L. (2024). Inhibiting cholesterol de novo synthesis promotes hepatocellular carcinoma progression by upregulating prostaglandin E synthase 2‐mediated arachidonic acid metabolism under high fatty acid conditions. Cancer Science. https://doi.org/10.1111/cas.16035
Vancouver
Zhao Z, Liu X, Xiang Y, Hou Z, He K, Zhong G, et al. Inhibiting cholesterol de novo synthesis promotes hepatocellular carcinoma progression by upregulating prostaglandin E synthase 2‐mediated arachidonic acid metabolism under high fatty acid conditions. Cancer Science. 2024. doi:10.1111/cas.16035
BibTeX
@article{Zhao2024,
author = {Zhao, Zhibo and Liu, Xinyi and Xiang, Yue and Hou, Zhengping and He, Kun and Zhong, Guochao and Hu, Jiejun and Cai, Dong and Liu, Yan and Ren, Jihua and Gong, Jianping and Zhao, Lei},
title = {Inhibiting cholesterol de novo synthesis promotes hepatocellular carcinoma progression by upregulating prostaglandin E synthase 2‐mediated arachidonic acid metabolism under high fatty acid conditions},
journal = {Cancer Science},
year = {2024},
doi = {10.1111/cas.16035}
}
EUVIMED